...
首页> 外文期刊>Histopathology: Official Journal of the British Division of the International Academy of Pathology >Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia.
【24h】

Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia.

机译:经针芯活检诊断为恶性潜能不确定(B3)或可疑恶性肿瘤(B4)的乳腺病变的结果,包括上皮非典型性病变的详细回顾。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: To provide updated evidence of the outcome of breast lesions of uncertain malignant potential (B3) and suspicious of malignancy (B4) diagnosed on needle core biopsy (NCB) and analyse the outcome of the different types of intraductal epithelial atypia. METHODS AND RESULTS: One-hundred and forty-nine B3 and 26 B4 NCBs diagnosed over a 2-year period (2007-2008) were compared with those diagnosed over a previous 2-year period (1998-2000). The proportion of B3 diagnoses increased from 3.1% to 4.5%, and the positive predictive value (PPV) of malignancy of a B3 core decreased from 25% to 10%. Increased diagnosis of radial scar and reductions in the PPV of lobular neoplasia and of atypical intraductal proliferation may explain the reduction in the PPV of the B3 group as a whole. There were no significant changes in the proportion of B4 diagnosis (1.1% and 0.8%) or the PPV of B4 (83% and 88%). Review of cores with intraductal atypia showed a wide range of PPVs, from 100% for suspicious of ductal carcinoma in situ, to 40% for atypical ductal hyperplasia categorized as B3, and 14% for isolated flat epithelial atypia. CONCLUSION: The study has found a decrease in the PPV for a B3 diagnosis and suggests possible explanations.
机译:目的:提供最新的证据,证明在针芯活检(NCB)上诊断出的恶性潜能(B3)和恶性(B4)可疑的乳腺病变的结果,并分析不同类型的导管内上皮异型症的结果。方法和结果:将两年(2007-2008年)诊断出的一百四十九个B3和26个B4 NCB与之前两年(1998-2000年)诊断出的NCB进行了比较。 B3诊断的比例从3.1%增加到4.5%,B3核心恶性肿瘤的阳性预测值(PPV)从25%降低到10%。放射状疤痕诊断的增加以及小叶赘生物和非典型导管内增生的PPV的降低可能解释了整个B3组PPV的降低。 B4诊断的比例(1.1%和0.8%)或B4的PPV(83%和88%)没有显着变化。对导管内非典型性的回顾表明,PPV的范围很广,从100%的可疑导管原位癌到40%的非典型导管增生归类为B3,以及14%的孤立性扁平上皮非典型性。结论:该研究发现B3诊断的PPV降低,并提出了可能的解释。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号